April 12, 2018 08:41 AM EDT

Does the FDA’s ‘breakthrough’ drug program need to be reformed? Harvard skeptics say yes

Of all the expedited review programs that the FDA has set up, none are as popular as the “breakthrough” therapy designation. And a group of …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

TRENDING NOW

Does the FDA’s ‘break­through’ drug pro­gram need to be re­formed? Har­vard skep­tics say yes